These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 24824243)
1. Potential association of hyperhomocysteinemia with the progression of IgA nephropathy: a retrospective study. Duan S; Liu S; Sun X; Zheng Y; Liu L; Yao F; Wu J Chin Med J (Engl); 2014; 127(10):1849-52. PubMed ID: 24824243 [TBL] [Abstract][Full Text] [Related]
2. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate. Okonogi H; Utsunomiya Y; Miyazaki Y; Koike K; Hirano K; Tsuboi N; Suzuki T; Hara Y; Ogura M; Hosoya T; Kawamura T Nephron Clin Pract; 2011; 118(3):c292-300. PubMed ID: 21212693 [TBL] [Abstract][Full Text] [Related]
3. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019 [TBL] [Abstract][Full Text] [Related]
4. Review of cases of IgA nephropathy. World MJ J R Army Med Corps; 2013 Jun; 159(2):90-3. PubMed ID: 23720589 [TBL] [Abstract][Full Text] [Related]
5. Primary glomerulonephritis: an update on renal survival and determinants of progression. Moranne O; Watier L; Rossert J; Stengel B; QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806 [TBL] [Abstract][Full Text] [Related]
6. The impact of sex in primary glomerulonephritis. Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S; Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran. Soleymanian T; Najafi I; Salimi BH; Broomand B Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387 [TBL] [Abstract][Full Text] [Related]
8. High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease. Ye Z; Zhang Q; Li Y; Wang C; Zhang J; Ma X; Peng H; Lou T Nutrients; 2016 Oct; 8(10):. PubMed ID: 27775590 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of hyperhomocysteinemia and its associated factors in patients with primary hypertension in Chinese urban communities: A cross-sectional study from Nanjing. Wang W; Ji P; Wang Y; Guo H; Bian R; Xu J; Xiong Y Clin Exp Hypertens; 2018; 40(5):495-500. PubMed ID: 29172835 [TBL] [Abstract][Full Text] [Related]
10. Association of Hyperhomocysteinemia with Stroke Recurrence after Initial Stroke. Kumral E; Saruhan G; Aktert D; Orman M J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2047-54. PubMed ID: 27260368 [TBL] [Abstract][Full Text] [Related]
11. Mortality in patients with IgA nephropathy. Knoop T; Vikse BE; Svarstad E; Leh S; Reisæter AV; Bjørneklett R Am J Kidney Dis; 2013 Nov; 62(5):883-90. PubMed ID: 23796906 [TBL] [Abstract][Full Text] [Related]
12. Low estimated glomerular filtration rate explains the association between hyperhomocysteinemia and in-hospital mortality among patients with ischemic stroke/transient ischemic attack or intracerebral hemorrhage: Results from the Chinese Stroke Center Alliance. Liu W; Ma XL; Gu HQ; Li H; Li ZX; Wang YJ Int J Stroke; 2023 Mar; 18(3):354-363. PubMed ID: 35672911 [TBL] [Abstract][Full Text] [Related]
13. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
14. Predicting progression in IgA nephropathy. Bartosik LP; Lajoie G; Sugar L; Cattran DC Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875 [TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and progression of IgA nephropathy. Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification of patients with IgA nephropathy. Barbour SJ; Reich HN Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792 [TBL] [Abstract][Full Text] [Related]
17. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR. Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226 [TBL] [Abstract][Full Text] [Related]
18. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586 [TBL] [Abstract][Full Text] [Related]
19. Factors predicting progression of IgA nephropathies. Coppo R; D'Amico G J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675 [TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia in pediatric and young adult renal transplant recipients. Belson A; Sanchez J; Alexander SR; Salvatierra O; Dar MH; Reif S; Yorgin PD Pediatr Transplant; 2004 Apr; 8(2):161-6. PubMed ID: 15049796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]